Asset management

With return targets growing ever more elusive, many investors are willing to take their chances with private debt and equity.

The pandemic has sealed the fate of small, niche offerings that have failed to gain traction.

The purchase comes as active asset managers feel intensifying pressure to bulk up as they face stiff competition from passive and index-tracking funds.

The combined fund, expected to finalize later this year, will retain the Windsor name and continue to focus on large- and mid-cap value stocks.

Even some of the industry’s cheapest products “may be overpriced” in that they’re “mirroring a passive index,” an expert says.

As policymakers fear a deflation spiral reminiscent of the Great Depression, contrarians wonder if ultra-loose monetary policies can inspire growth.

It’s the latest example of how firms who spent the past decade battling low yields are now raising cash to seize on deep discounts from the coronavirus.

This year’s honorees discuss how their firms are coping with the coronavirus pandemic and how this period may reshape the industry.

Hedge fund managers, market academics and risk experts are channeling their data-mining smarts to the world of clinical sciences.

With the industry facing ridicule for high fees and low returns, clients have pulled a net $33 billion from the industry in the first quarter, the most over a decade.